Nuwellis (NUWE) Short-term Investments (2021 - 2023)

Nuwellis (NUWE) reported Short-term Investments of $575000.0 for Q1 2023, up 1.05% quarter-over-quarter from $569000.0 in Q4 2022.

Nuwellis (NUWE) Short-term Investments (2021 - 2023) Analysis & Trends

Nuwellis has reported Short-term Investments for 3 years, with the latest figure at $575000.0 in Q1 2023.

  • For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $575000.0; the trailing twelve-month figure through Mar 2023 stood at $575000.0 (changed N/A YoY), and the FY2022 full-year result was $569000.0, down 96.32% from the prior year.
  • Short-term Investments for Q1 2023 stood at $575000.0, up from $569000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $15.5 million in Q4 2021, with the low at $569000.0 in Q4 2022.
  • Historically, Short-term Investments has averaged $5.5 million across 3 years, with a median of $575000.0 in 2023.
  • The largest YoY upside for Short-term Investments was 96.32% in 2022 against a maximum downside of 96.32% in 2022.
  • Nuwellis' Short-term Investments stood at $15.5 million in 2021, then tumbled by 96.32% to $569000.0 in 2022, then increased by 1.05% to $575000.0 in 2023.
  • The last three Short-term Investments figures came in at $575000.0 (Q1 2023), $569000.0 (Q4 2022), and $15.5 million (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 575,000.00
Dec 31, 2022 569,000.00
Dec 31, 2021 15.46 Mn